Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue ANN ARBOR, MI / ACCESS New ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...
Quest Diagnostics has outpaced its healthcare peers over the past year, and analysts are maintaining a moderately positive ...
New tests recommended by the WHO can address TB cases with no or few symptoms more quickly and improve access to life-saving treatment.
In a study published in Nature Medicine, researchers from the University of Oxford and the Muhimbili University of Health and ...
Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...
Don't give up on this leading dividend payer yet.
Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading multi-regional medical laboratory in the ...
More than 1,000 samples have been enrolled in the Pattern Bioscience clinical trial evaluating the Pattern Pneumonia ID/AST Panel and Pattern System ...
A new simulator module can help clinicians learn to detect painful adhesions caused by deep infiltrating endometriosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results